Close Menu

NEW YORK – Roche announced Monday the launch of its Cobas Zika test in countries that accept the CE mark.

The in vitro nucleic acid screening test detects Zika virus RNA in samples of human plasma and is intended to be used for screening blood donations with Roche's fully automated Cobas 6800/8800 systems.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

Antibody testing is expected to play an important role in the management of the COVID-19 pandemic. 


As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.